Author

Q. P. Hammarstrom

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:whole-exome sequencing· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

B. Zhang· 1 shared D. Liu· 1 shared F. Zhang· 1 shared J. A. Fuenzalida· 1 shared J. Joung· 1 shared K. Wu· 1 shared L. Du· 1 shared M. Nie· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. Zhang

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Essentiality of CREBBP in EP300 truncated B-cell lymphoma revealed by genome-wide CRISPR-Cas9 screen

M. Nie, B. Zhang, L. Du, W. Ren, J. Joung, X. Ye, J. A. Fuenzalida, X. Shi, D. Liu, K. Wu, F. Zhang, Q. P. Hammarstrom

The paper identifies CREBBP dependency in a DLBCL cell line with EP300 truncation using CRISPR-Cas9 screens and genomic data, suggesting therapeutic targets for heterogeneous cancers.

bioRxiv · Aug 28, 2019 · PreprintCancer Biology